Back to venturesActive
OX
OncoX
2025
Cutting-Edge Therapeutics & Treatments to eventually help solve Cancer
Pharmaceuticals
Total Raised
-
Team
15
Revenue
Pre-Revenue
Exit Value
—
Overview
We are commercialising groundbreaking achievements being carried out in Cancer Research
The Problem
Cancer
Our Solution
Aggressively get in touch with laboratories worldwide, doing pioneering research in Cancer Therapeutics, offer them our commercialisation Expertise. Scale.
Traction
- Introducing Novel Lung-Cancer Diagnostics to Indian Market which reduces TAT for Liquid Biopsies from 30 days to 2 days
- MOU's signed to make the product profitable in Year 1
- 2 drugs in Pipeline
Looking Ahead
INR 500CR+ Annualised Revenue expected by 2032